Evidence map›Paper›PMID 40631882›Full record

ArticleBrain : a journal of neurology2025

Selective vulnerability and resilience to Alzheimer's disease tauopathy as a function of genes and the connectome.

Chaitali Anand, Farras Abdelnour, Benjamin Sipes, Daren Ma, Pedro D Maia, Justin Torok, Ashish Raj

Abstract read
In one paragraph

Article in Brain : a journal of neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Emerging directions in tauopathy research.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Review
  8. Gene-Modulated Network Diffusion for Improved Modeling of Amyloid-bioRxiv : the preprint server for biology · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Frontiers in aging neuroscience · 2026
    Review
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Chaitali AnandInstitute for Neurodegenerative Diseases, University of California, San Francisco, CA 94158, USA.ORCID 0000-0002-1755-2202
Farras AbdelnourBrain Networks Laboratory, Department of Radiology, University of California, San Francisco, CA 94122, USA.
Benjamin SipesBrain Networks Laboratory, Department of Radiology, University of California, San Francisco, CA 94122, USA.
Daren MaBrain Networks Laboratory, Department of Radiology, University of California, San Francisco, CA 94122, USA.
Pedro D MaiaDepartment of Mathematics, University of Texas at Arlington, Arlington, TX 76019, USA.ORCID 0000-0002-3335-4257
Justin TorokBrain Networks Laboratory, Department of Radiology, University of California, San Francisco, CA 94122, USA.
Ashish RajBrain Networks Laboratory, Department of Radiology, University of California, San Francisco, CA 94122, USA.

Funding

Understanding the dynamic interactions between tau pathology and microgliamediated inflammation in Alzheimer's DiseaseR01AG072753 · NIA · WEILL MEDICAL COLL OF CORNELL UNIV · PI BUTLER, TRACY A., GUPTA, AJAY · 2021 to 2025
$5.3M
Network Modelling of Multimodal Dynamics in Alzheimer’s Disease and DementiaRF1AG062196 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI NAGARAJAN, SRIKANTAN S., RAJ, ASHISH · 2019 to 2019
$3.0M
Predictive model of spread of Parkinson's pathology using network diffusionR01NS092802 · NINDS · WEILL MEDICAL COLL OF CORNELL UNIV · PI GUPTA, AJAY, RAJ, ASHISH · 2016 to 2020
$2.8M
Mathematical modeling of selective vulnerability of genes, cells and network in mouse tauopathyRF1AG087302 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI RAJ, ASHISH · 2024 to 2024
$2.1M
Understanding the dynamic interactions between tau pathology and microglia-mediated inflammation in Alzheimer's DiseaseR56AG064873 · NIA · WEILL MEDICAL COLL OF CORNELL UNIV · PI GUPTA, AJAY, RAJ, ASHISH · 2019 to 2019
$771k
Computational dissection of cellular and network vulnerability in Alzheimer's and related dementiasR56AG082087 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI RAJ, ASHISH · 2023 to 2023
$761k
Exploring the differential spreading of distinct pathological conformers of AD/LBD-related proteins by combining mathematical modeling and functional studyR21AG087921 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI PENG, CHAO, RAJ, ASHISH · 2024 to 2025
$441k
NIA NIH HHS R01 AG072753NIA NIH HHS R21 AG087921NIA NIH HHS R56 AG064873NIA NIH HHS R56 AG082087NIA NIH HHS RF1 AG062196NIA NIH HHS RF1 AG087302NIH HHS R01AG072753NIH HHS R01NS092802NIH HHS RF1AG062196NINDS NIH HHS R01 NS092802
6 · The paper itself

Abstract

Brain regions in Alzheimer's disease exhibit distinct vulnerability to its hallmark pathology with the entorhinal cortex and hippocampus succumbing early to tau tangles while others like the primary sensory cortices remain resilient. The quest to understand how local/regional genetic factors, pathogenesis and network-mediated pathology spread, together govern this selective vulnerability (SV) or resilience (SR) is ongoing. Although many Alzheimer's risk genes are known from gene association and transgenic studies, it is still unclear whether and how their baseline expression confers SV/SR to pathology. Prior analyses have yielded conflicting results, pointing to a disconnect between the location of genetic risk factors and downstream tau pathology. The spatial distribution of vulnerability doesn't always align with genetic factors, suggesting a role for non-cell-autonomous mechanisms like transneuronal tau transmission. We hypothesize that a full accounting of the role of genes in mediating SV/SR would require modelling of network-based vulnerability, whereby tau misfolds, aggregates and propagates along fibre projections. We employed an extended network diffusion model (eNDM) and fitted it on tau PET data from 196 patients from the Alzheimer's Disease Neuroimaging Initiative. The fitted eNDM then becomes a reference from which to assess the role of innate genetic factors. Using the residual (observed - model-predicted) tau as a novel target outcome, we obtained its association with 100 Alzheimer's risk genes, whose baseline spatial transcriptional profiles were obtained from the Allen Human Brain Atlas. Our eNDM was successful in capturing tau pathology distribution in patients. After regressing out the model, we found that while many risk genes have spatial expression patterns that correlate with regional tau, many others showed a stronger association with residual tau. This suggests that direct vulnerability aligned with the network, as well as network-independent vulnerability, are conferred by risk genes. We report four classes of risk genes: network-aligned SV (SV-NA), network-independent SV (SV-NI), network-aligned SR (SR-NA) and network-independent SR (SR-NI), each with a distinct spatial signature and associated vulnerability to tau. Remarkably, using gene ontology analysis, we found that the identified gene classes have distinct and sometimes surprising functional enrichment patterns. Network-aligned genes broadly participate in cell death, stress response and metabolic processing; network-independent genes in amyloid-β processing and immune response. These previously unreported segregated roles point to multiple distinct pathways by which risk genes confer vulnerability or resilience in Alzheimer's disease. Our findings offer new insights into vulnerability signatures in Alzheimer's disease and may prove helpful in identifying potential intervention targets.

Indexed as

Alzheimer DiseaseBrainConnectomeTauopathiesAgedAged, 80 and overFemaleGenetic Predisposition to DiseaseHumansMalePositron-Emission Tomographytau Proteinstau ProteinsAlzheimer’s tauopathygenesnetwork diffusionselective resilienceselective vulnerability

Identifiers

PMID40631882
PMCPMC12493037

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.